Literature DB >> 11341868

Prophylaxis of Venous Thrombosis.

Samuel Z. Goldhaber1.   

Abstract

Mechanical measures such as graduated compression stockings and intermittent compression boots are available for venous thrombosis prophylaxis, but compliance may be limited. Plantar venous pneumatic compression devices have attained widespread acceptance by both patients and nurses because of their comfort and compact size, but their track record for efficacy is poor. Inferior vena cava filters prevent pulmonary embolism, but do not halt the thrombotic process or prevent venous thrombosis. Pharmacologic prophylaxis traditionally has relied upon minidose unfractionated heparin; however, re-examination is warranted in the face of increasingly ill and complex patients. My opinion is that small, fixed doses of once-daily low molecular weight heparin will eventually replace minidose unfractionated heparin as the standard pharmacologic prophylaxis regimen for most surgical and medical patients. Prolongation of prophylaxis after hospital discharge should receive increased emphasis. Most patients being transferred to a skilled nursing facility should receive venous thromboembolism prophylaxis. Similarly, most patients undergoing total hip or knee replacement should receive prolonged preventive regimens, with at least 1 month of anticoagulation. Despite advances, certain aspects of venous thrombosis prophylaxis remain problematic. First, a surprisingly high number of hospitalized patients develop venous thrombosis because of failed (rather than omitted) prophylaxis. Second, many patients in intensive care have a combination of peripheral vascular disease and active bleeding (usually gastrointestinal) that precludes mechanical or pharmacologic prophylaxis. Third, neurosurgical patients undergoing craniotomy for brain tumors suffer a high rate of venous thrombosis and major pulmonary embolism despite the routine use of combined mechanical and pharmacologic prophylaxis. My opinion is that these three areas, in addition to the hospital culture of prophylaxis, should receive increased attention in an effort to prevent venous thromboembolism.

Entities:  

Year:  2001        PMID: 11341868     DOI: 10.1007/s11936-001-0041-6

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  31 in total

1.  Inferior vena caval filters: review of a 26-year single-center clinical experience.

Authors:  C A Athanasoulis; J A Kaufman; E F Halpern; A C Waltman; S C Geller; C M Fan
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

2.  A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.

Authors:  H Decousus; A Leizorovicz; F Parent; Y Page; B Tardy; P Girard; S Laporte; R Faivre; B Charbonnier; F G Barral; Y Huet; G Simonneau
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

Review 3.  Low-molecular-weight heparins.

Authors:  J I Weitz
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

4.  Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis.

Authors:  H Halkin; J Goldberg; M Modan; B Modan
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

Review 5.  Safety of low-molecular-weight heparin in pregnancy: a systematic review.

Authors:  B J Sanson; A W Lensing; M H Prins; J S Ginsberg; Z S Barkagan; E Lavenne-Pardonge; B Brenner; M Dulitzky; J D Nielsen; Z Boda; S Turi; M R Mac Gillavry; K Hamulyák; I M Theunissen; B J Hunt; H R Büller
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

6.  The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.

Authors:  A J Comerota; V Chouhan; R N Harada; L Sun; J Hosking; R Veermansunemi; A J Comerota; D Schlappy; A K Rao
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

7.  Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172)

Authors:  H N Magnani
Journal:  Thromb Haemost       Date:  1993-10-18       Impact factor: 5.249

8.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

9.  Prevalence of deep venous thrombosis among patients in medical intensive care.

Authors:  D R Hirsch; E P Ingenito; S Z Goldhaber
Journal:  JAMA       Date:  1995-07-26       Impact factor: 56.272

10.  Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.

Authors:  R H White; P S Romano; H Zhou; J Rodrigo; W Bargar
Journal:  Arch Intern Med       Date:  1998-07-27
View more
  3 in total

Review 1.  Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.

Authors:  Stavros Kakkos; George Kirkilesis; Joseph A Caprini; George Geroulakos; Andrew Nicolaides; Gerard Stansby; Daniel J Reddy
Journal:  Cochrane Database Syst Rev       Date:  2022-01-28

2.  Reducing inappropriately suspended VTE prophylaxis through a multidisciplinary shared learning programme and electronic prompting.

Authors:  Christopher Felix Brewer; Dorothy Ip; Emma Drasar; Poureya Aghakhani
Journal:  BMJ Open Qual       Date:  2019-03-01

Review 3.  Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.

Authors:  Stavros K Kakkos; Joseph A Caprini; George Geroulakos; Andrew N Nicolaides; Gerard Stansby; Daniel J Reddy; Ioannis Ntouvas
Journal:  Cochrane Database Syst Rev       Date:  2016-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.